La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prospective prevalence of pathologic gambling and medication association in Parkinson disease.

Identifieur interne : 002717 ( Main/Exploration ); précédent : 002716; suivant : 002718

Prospective prevalence of pathologic gambling and medication association in Parkinson disease.

Auteurs : V. Voon [États-Unis] ; K. Hassan ; M. Zurowski ; S. Duff-Canning ; M. De Souza ; S. Fox ; A E Lang ; J. Miyasaki

Source :

RBID : pubmed:16769956

English descriptors

Abstract

The authors prospectively screened 297 patients with Parkinson disease (PD), who attended a tertiary clinic, using a modified South Oaks Gambling Scale. Lifetime prevalence of pathologic gambling (PG) was 3.4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist.

DOI: 10.1212/01.wnl.0000218206.20920.4d
PubMed: 16769956


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Prospective prevalence of pathologic gambling and medication association in Parkinson disease.</title>
<author>
<name sortKey="Voon, V" sort="Voon, V" uniqKey="Voon V" first="V" last="Voon">V. Voon</name>
<affiliation wicri:level="2">
<nlm:affiliation>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1428, USA. voonv@ninds.nih.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1428</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hassan, K" sort="Hassan, K" uniqKey="Hassan K" first="K" last="Hassan">K. Hassan</name>
</author>
<author>
<name sortKey="Zurowski, M" sort="Zurowski, M" uniqKey="Zurowski M" first="M" last="Zurowski">M. Zurowski</name>
</author>
<author>
<name sortKey="Duff Canning, S" sort="Duff Canning, S" uniqKey="Duff Canning S" first="S" last="Duff-Canning">S. Duff-Canning</name>
</author>
<author>
<name sortKey="De Souza, M" sort="De Souza, M" uniqKey="De Souza M" first="M" last="De Souza">M. De Souza</name>
</author>
<author>
<name sortKey="Fox, S" sort="Fox, S" uniqKey="Fox S" first="S" last="Fox">S. Fox</name>
</author>
<author>
<name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name>
</author>
<author>
<name sortKey="Miyasaki, J" sort="Miyasaki, J" uniqKey="Miyasaki J" first="J" last="Miyasaki">J. Miyasaki</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16769956</idno>
<idno type="pmid">16769956</idno>
<idno type="doi">10.1212/01.wnl.0000218206.20920.4d</idno>
<idno type="wicri:Area/PubMed/Corpus">001161</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001161</idno>
<idno type="wicri:Area/PubMed/Curation">001161</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001161</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001161</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001161</idno>
<idno type="wicri:Area/Ncbi/Merge">000651</idno>
<idno type="wicri:Area/Ncbi/Curation">000651</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000651</idno>
<idno type="wicri:Area/Main/Merge">002993</idno>
<idno type="wicri:Area/Main/Curation">002717</idno>
<idno type="wicri:Area/Main/Exploration">002717</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Prospective prevalence of pathologic gambling and medication association in Parkinson disease.</title>
<author>
<name sortKey="Voon, V" sort="Voon, V" uniqKey="Voon V" first="V" last="Voon">V. Voon</name>
<affiliation wicri:level="2">
<nlm:affiliation>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1428, USA. voonv@ninds.nih.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1428</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hassan, K" sort="Hassan, K" uniqKey="Hassan K" first="K" last="Hassan">K. Hassan</name>
</author>
<author>
<name sortKey="Zurowski, M" sort="Zurowski, M" uniqKey="Zurowski M" first="M" last="Zurowski">M. Zurowski</name>
</author>
<author>
<name sortKey="Duff Canning, S" sort="Duff Canning, S" uniqKey="Duff Canning S" first="S" last="Duff-Canning">S. Duff-Canning</name>
</author>
<author>
<name sortKey="De Souza, M" sort="De Souza, M" uniqKey="De Souza M" first="M" last="De Souza">M. De Souza</name>
</author>
<author>
<name sortKey="Fox, S" sort="Fox, S" uniqKey="Fox S" first="S" last="Fox">S. Fox</name>
</author>
<author>
<name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name>
</author>
<author>
<name sortKey="Miyasaki, J" sort="Miyasaki, J" uniqKey="Miyasaki J" first="J" last="Miyasaki">J. Miyasaki</name>
</author>
</analytic>
<series>
<title level="j">Neurology</title>
<idno type="eISSN">1526-632X</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Dopamine Agents (therapeutic use)</term>
<term>Female</term>
<term>Gambling</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Ontario (epidemiology)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Prevalence</term>
<term>Prospective Studies</term>
<term>Risk Assessment (methods)</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Dopamine Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Ontario</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Risk Assessment</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Female</term>
<term>Gambling</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Prospective Studies</term>
<term>Risk Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The authors prospectively screened 297 patients with Parkinson disease (PD), who attended a tertiary clinic, using a modified South Oaks Gambling Scale. Lifetime prevalence of pathologic gambling (PG) was 3.4% and on any dopamine agonist was 7.2%. PG was associated with earlier PD onset and with dopamine agonists but not with agonist subtype or doses. We found no association with a potent D3 receptor agonist.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="De Souza, M" sort="De Souza, M" uniqKey="De Souza M" first="M" last="De Souza">M. De Souza</name>
<name sortKey="Duff Canning, S" sort="Duff Canning, S" uniqKey="Duff Canning S" first="S" last="Duff-Canning">S. Duff-Canning</name>
<name sortKey="Fox, S" sort="Fox, S" uniqKey="Fox S" first="S" last="Fox">S. Fox</name>
<name sortKey="Hassan, K" sort="Hassan, K" uniqKey="Hassan K" first="K" last="Hassan">K. Hassan</name>
<name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name>
<name sortKey="Miyasaki, J" sort="Miyasaki, J" uniqKey="Miyasaki J" first="J" last="Miyasaki">J. Miyasaki</name>
<name sortKey="Zurowski, M" sort="Zurowski, M" uniqKey="Zurowski M" first="M" last="Zurowski">M. Zurowski</name>
</noCountry>
<country name="États-Unis">
<region name="Maryland">
<name sortKey="Voon, V" sort="Voon, V" uniqKey="Voon V" first="V" last="Voon">V. Voon</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002717 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002717 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16769956
   |texte=   Prospective prevalence of pathologic gambling and medication association in Parkinson disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16769956" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022